NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3
- 6 May 2004
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 89-90, 457-459
- https://doi.org/10.1016/j.jsbmb.2004.03.017
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Analogs of 1α,25‐dihydroxyvitamin D3 as pluripotent immunomodulatorsJournal of Cellular Biochemistry, 2003
- A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD MiceDiabetes, 2002
- Dendritic cell modulation by 1α,25 dihydroxyvitamin D3and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturityin vitroandin vivoProceedings of the National Academy of Sciences, 2001
- Recent developments in the use of vitamin D analoguesExpert Opinion on Investigational Drugs, 2000
- PREVENTION OF AUTOIMMUNE DESTRUCTION OF SYNGENEIC ISLET GRAFTS IN SPONTANEOUSLY DIABETIC NONOBESE DIABETIC MICE BY A COMBINATION OF AVITAMIN D3 ANALOG AND CYCLOSPORINE1Transplantation, 1998
- Prevention of Type I Diabetes in Nonobese Diabetic Mice by Late Intervention with Nonhypercalcemic Analogs of 1,25-Dihydroxyvitamin D3 in Combination with a Short Induction Course of Cyclosporin AEndocrinology, 1998
- Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060Endocrinology, 1995
- Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3Diabetologia, 1994
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD miceDiabetes, 1992